Achieve Life (ACHV) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ACHV Achieve Life

Watchlist

4.475
-0.085-1.86%

Trading Dec 4 14:11 ET

153.90MMarket Cap-3995P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Achieve Life To Advance Cytisinicline Into Phase 3 Study For Vaping Cessation In Q3, 2025
RTTNewsDec 3 10:15 ET
Achieve Life Sciences Announces Outcome of End-of-Phase 2 Meeting With FDA
TipRanksDec 3 08:40 ET
Express News | Achieve Life Sciences Inc - Expects to File Nda for Smoking Cessation in Q2 2025
ReutersDec 3 08:31 ET
Express News | Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting With FDA
ReutersDec 3 08:30 ET
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
Achieve LifeNov 14 08:30 ET
This Turning Point Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
BenzingaNov 14 07:53 ET

Comments

MindOverMatter

Aug 13 19:03

$Achieve Life (ACHV.US)$

Jaguar8

May 29 07:01

NEWS

$Achieve Life (ACHV.US)$
Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes
Achieve Life Sciences has initiated the ORCA-OL clinical trial to evaluate the long-term safety of cytisinicline, a treatment for smoking and nicotine dependence. The open-label trial involves 29 U.S. sites and aims to collect data required for a New Drug Application (NDA) submission expected in the first ...